1 / 17

Pandemic H1N1 Vaccination

Pandemic H1N1 Vaccination. District Model Micro-planning Booklet. District Pandemic Vaccine Preparedness Plan – Suggested Contents. Objectives To protect those most at risk of infection with pandemic influenza A H1N1 virus.

derry
Télécharger la présentation

Pandemic H1N1 Vaccination

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pandemic H1N1 Vaccination District Model Micro-planning Booklet

  2. District Pandemic Vaccine Preparedness Plan – Suggested Contents

  3. Objectives • To protect those most at risk of infection with pandemic influenza A H1N1 virus. • To prioritize and vaccinate health care workers to ensure that the health facilities providing medical care / H1N1 care are able to continue its operations.

  4. Demographic Details • Name of district • Total population • Number of health facilities involved in H1N1 care • Government • Private • Target Population • Total • Male • Female

  5. PANENZA-Pandemic Vaccine • Panenza is a split virus inactivated, non-adjuvanted monovalent vaccine The active ingredient is:  Split Influenza virus*, inactivated, containing antigen equivalent to: A/California/7/2009 (H1N1)v-like strain (NYMC X-179A) ..............15 micrograms** per 0.5 ml dose * propagated in eggs ** expressed in microgram haemagglutinin • The other ingredients are: thiomersal (45 micrograms per 0.5 ml dose), sodium chloride, potassium chloride, disodium phosphate dihydrate, potassium dihydrogen phosphate, and water. • PANENZA is a suspension for injection in a multidose vial (10 doses of 0.5ml) - Pack of 10 vials. The suspension is a colourless liquid, clear to opalescent. • Vaccine administration: One dose (0.5 ml) intra muscular [for the defined target group as defined in the objective]

  6. H1N1 Vaccination Tally Sheet

  7. H1N1 Reporting Sheet

  8. List of Vaccinators and Supervisors

  9. AEFI Committee

  10. TIME LINE OF ACTIVITIES : H1N1 Vaccination Mar / Apr 2010 --.--.2010 1st State Coordination Committee Meeting --.--.2010 Procurement of Vaccine --.--.2010 2nd State Coordination Committee Meeting --.--.2010 :State level DHOs meeting --.--.2010 Microplan Submission to State --.--.2010 District level Procurement of vaccine logistics formats --.--.2010 District Coordination Committee Meeting Planning Cycle --.--.2010 Vaccinators & Supervisors Training. H1N1 Vaccination Dates – --- , ---Mar / --, ----Apr 2010

More Related